Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David El-Qutob

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Recent Patents on Inflammation & Allergy Drug Discovery|March 12, 2015
Peptide-based allergen specific immunotherapy for the treatment of allergic disordersDavid El-Qutob, Pedro Reche, José L Subiza, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2017
Mammalian raw materials used to produce allergen extractsEnrique Fernández-Caldas, Bárbara Cases, David El-Qutob, et al.
Frontiers in Allergy|June 29, 2026
Molecular profiling of IgE sensitization to dermatophagoides allergen components: clinical correlates in a high-exposure regionDavid El-Qutob, María Dolores Martos Calahorro, Ángel Ferrer Torres, et al.
Reumatologia Clinica|September 20, 2021
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infectionMontserrat Robustillo-Villarino, Laura Álvarez-Arroyo, Francisco Javier Carrera-Hueso, et al.
Reumatologia Clinica|May 14, 2021
Characteristics of Patients With Immune-Mediated Inflammatory Diseases Hospitalized for SARS-CoV-2 InfectionMontserrat Robustillo-Villarino, Laura Álvarez-Arroyo, Francisco Javier Carrera-Hueso, et al.
Journal of Asthma and Allergy|July 16, 2016
Adverse reactions and tolerability of high-dose sublingual allergen immunotherapyAngel Moral, Victoria Moreno, Francisco Girón, et al.
Gaceta Medica De Mexico|June 14, 2021
Descriptive study of a cohort of COVID-19 hospitalized patients in SpainLaura Álvarez-Arroyo, Francisco J Carrera-Hueso, David El-Qutob, et al.
Allergy|May 16, 2022
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapyAntonio Nieto, Ángel Mazón, María Nieto, et al.
International Archives of Allergy and Immunology|August 15, 2021
Safety and Effectiveness of a Single Multiallergen Subcutaneous Immunotherapy in Polyallergic PatientsSantiago Nevot-Falcó, Eloina Gonzalez Mancebo, Antonio Martorell, et al.
Journal of Investigational Allergology & Clinical Immunology|February 13, 2026
Precision Medicine in Allergic Rhinitis and Conjunctivitis: Integrative Molecular Mapping of the Allergic Exposome in Spain (EXPOMOL Study)Ruperto González-Pérez, Paloma Poza-Guedes, Juan M Igea Aznar, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Recent Patents on Inflammation & Allergy Drug Discovery|March 12, 2015
Peptide-based allergen specific immunotherapy for the treatment of allergic disordersDavid El-Qutob, Pedro Reche, José L Subiza, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 3, 2017
Mammalian raw materials used to produce allergen extractsEnrique Fernández-Caldas, Bárbara Cases, David El-Qutob, et al.
Frontiers in Allergy|June 29, 2026
Molecular profiling of IgE sensitization to dermatophagoides allergen components: clinical correlates in a high-exposure regionDavid El-Qutob, María Dolores Martos Calahorro, Ángel Ferrer Torres, et al.
Reumatologia Clinica|September 20, 2021
Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infectionMontserrat Robustillo-Villarino, Laura Álvarez-Arroyo, Francisco Javier Carrera-Hueso, et al.
Reumatologia Clinica|May 14, 2021
Characteristics of Patients With Immune-Mediated Inflammatory Diseases Hospitalized for SARS-CoV-2 InfectionMontserrat Robustillo-Villarino, Laura Álvarez-Arroyo, Francisco Javier Carrera-Hueso, et al.
Journal of Asthma and Allergy|July 16, 2016
Adverse reactions and tolerability of high-dose sublingual allergen immunotherapyAngel Moral, Victoria Moreno, Francisco Girón, et al.
Gaceta Medica De Mexico|June 14, 2021
Descriptive study of a cohort of COVID-19 hospitalized patients in SpainLaura Álvarez-Arroyo, Francisco J Carrera-Hueso, David El-Qutob, et al.
Allergy|May 16, 2022
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapyAntonio Nieto, Ángel Mazón, María Nieto, et al.
International Archives of Allergy and Immunology|August 15, 2021
Safety and Effectiveness of a Single Multiallergen Subcutaneous Immunotherapy in Polyallergic PatientsSantiago Nevot-Falcó, Eloina Gonzalez Mancebo, Antonio Martorell, et al.
Journal of Investigational Allergology & Clinical Immunology|February 13, 2026
Precision Medicine in Allergic Rhinitis and Conjunctivitis: Integrative Molecular Mapping of the Allergic Exposome in Spain (EXPOMOL Study)Ruperto González-Pérez, Paloma Poza-Guedes, Juan M Igea Aznar, et al.
Pageof 2